Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 18/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29603846 | 0.85 | ABL1 (0.59) | LMNAMAPTCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL1457517 | 0.85 | ABL1 (0.59) | LMNAMAPTCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL807443 | 0.85 | ABL1 (0.59) | LMNAMAPTCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL14281155 | 0.84 | ERN1 (0.47) | ERN1CYP3A4 | |
| SCHEMBL4632508 | 0.82 | TUBB1 (0.56) | LMNAMAPTCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL152269 | 0.82 | TUBB1 (0.56) | LMNAMAPTCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL30393705 | 0.82 | ERN1 (0.68) | ERN1LMNAMAPT | |
| SCHEMBL326755 | 0.82 | ERN1 (0.68) | ERN1LMNAMAPT | |
| SCHEMBL8679776 | 0.82 | ERN1 (0.68) | ERN1LMNAMAPT | |
| SCHEMBL13176833 | 0.80 | PTGS1 (0.54) | MAPTCYP1A2CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11826396-B2 | Nutriprotective diet | FEDERATION DES PRODUCTEURS ACERICOLES DU QUEBEC (CA) | 2023-11-28 | — | — | US | disclosed |
| US-20210156060-A1 | LOW BASIS WEIGHT FLAME RETARDANT SCRIM, ARTICLES, AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY | 2021-05-27 | — | — | US | disclosed |
| US-20190070245-A1 | NUTRIPROTECTIVE DIET | FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) | 2019-03-07 | — | — | US | disclosed |
| US-9922741-B2 | Method for the pre-calcining treatment of an aqueous nitric solution comprising at least one radionuclide and optionally ruthenium | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2018-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11826396-B2 | Nutriprotective diet | NEFM, NNMT, SORD | ERN1 4711/4885LMNA 2732/4885MAPT 126/4885 |
| US-20190070245-A1 | NUTRIPROTECTIVE DIET | NEFM, NNMT, SORD | ERN1 4711/4885LMNA 2732/4885MAPT 126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.